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OBJECTIVE — To determine the impact of the International Association of Diabetes and
Pregnancy Study Group (IADPSG) criteria on 1) gestational diabetes mellitus (GDM) diagnosis
compared with the American Diabetes Association (ADA) criteria and 2) the fasting plasma
glucose (FPG) to predict GDM.
RESEARCH DESIGN AND METHODS — In 10,283 pregnant women undergoing a
75-g oral glucose tolerance test (OGTT) for universal screening of GDM, two FPG thresholds
(of the OGTT) were used to rule in and to rule out GDM.
RESULTS — The IADPSG and ADA criteria identiﬁed GDM in 3,875 (37.7%) women and
1,328(12.9%)women,respectively(P0.0005).FPGthresholdsof5.1mmol/lruledinGDM
in 2,975 (28.9%) women with 100% speciﬁcity, while 4.4 mmol/l ruled out GDM in 2,228
(21.7%) women with 95.4% sensitivity. FPG independently could have avoided the OGTT in
5,203 (50.6%) women.
CONCLUSIONS — The IADPSG criteria increased GDM prevalence nearly threefold. By
circumventing a signiﬁcant number of OGTTs, an initial FPG can greatly simplify the IADPSG
diagnostic algorithm.
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T
he scourge of gestational diabetes
mellitus (GDM) is the lack of an in-
ternational agreement on the
screening and diagnosis among the pre-
eminent diabetes, obstetric, and health
careorganizations(1).Therefore,without
a globally accepted guideline, the diagno-
sis of GDM causes a great deal of clinical
confusion (2). In March 2010, the Inter-
nationalAssociationofDiabetesandPreg-
nancy Study Group (IADPSG) issued
consensus guidelines to potentially attain
a single approach for GDM diagnosis
worldwide (3).
The inconsistency in GDM diagnosis
is evident in the United Arab Emirates
(UAE), which has the second highest
prevalence of type 2 diabetes (18.7%) in
the world (4). GDM in the UAE varies
from 7.9 to 24.9%, depending on which
of the six well-accepted criteria are used
for diagnosis (2). The popular American
Diabetes Association (ADA) criteria (5)
demonstrates a prevalence of 10.6–
14.7% (2,6–8). In this population, mul-
tiple studies have conﬁrmed that the
initial fasting plasma glucose (FPG) result
of the oral glucose tolerance test (OGTT)
is excellent in determining the need to
continue with the OGTT (6,9–10); how-
ever, its efﬁciency depends on the criteria
used for GDM diagnosis (6). The aim of
this study was to determine, in this high-
risk population, the impact of the new
IADPSG criteria on 1) the diagnosis of
GDM compared with the ADA criteria
and2)theFPGtopredictGDMinorderto
decide whether to proceed with the
OGTT.
RESEARCH DESIGN AND
METHODS— The subjects were
pregnant women attending the routine
antenatal clinics of two tertiary care hos-
pitals. Due to a universal screening pro-
gram, every pregnant woman underwent
a 75-g OGTT scheduled at 24–28 weeks
gestation.Thedatawerecollatedfromour
four previous studies (2,6–8) between
2003 and 2008; a total of 10,283 preg-
nant women were available for analysis.
Plasma glucose was estimated by the
glucose oxidase method (Beckman-
Coulter, Brea, CA); the analytical stan-
dards for glucose were met (11).
Previously, the gold standard was the
ADA criteria (5) for the 75-g OGTT; the
data were reanalyzed using the new
IADPSG criteria (i.e., one or more plasma
venous glucose values 0 h, 5.1 mmol/l;
1 h, 10.0 mmol/l; or 2 h, 8.5 mmol/l) (3).
The statistical analysis has been de-
scribed earlier (6). A rule-in and rule-out
algorithm (12) was used for the FPG to
predict GDM. Brieﬂy, this approach in-
volvesconsideringtwoFPGcutoffvalues.
The higher threshold, with an inherently
increased speciﬁcity, rules in GDM; the
lower threshold, with its innate increased
sensitivity, rules out GDM. Women who
have FPG values in between these two
thresholds are indeterminate and would
need the diagnostic OGTT.
RESULTS— The current ADA crite-
ria identiﬁed 1,328 (12.9%) women
with GDM; however, by the new
IADPSG criteria (applied to the same
OGTT), 3,875 (37.7%) women would
have GDM (P  0.0005) (i.e., a 2.9-fold
increase). The mean maternal age was
(means  SD) 28.3  6.1 years. The
mean gestational age (at time of OGTT)
was25.6 6.3weeks.Thewomenwith
GDM (with either the ADA or IADPSG
criteria) were older with higher fasting,
1-h,and2-hplasmaglucosevalues(P 
0.0005). There were two main ethnic
groups: 8,233 (80.1%) Arab women
and 1,592 (15.5%) South-Asian women
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ladesh, and Sri Lanka). There was no
signiﬁcant difference in GDM diagnosis
between Arabs and South Asians with
IADPSGcriteria(P  0.3);nevertheless,
with the ADA criteria the difference was
signiﬁcant (P  0.0005).
The IADPSG criteria identiﬁed all
womenwithGDMbytheADAcriteriabut
categorized an additional 2,547 (24.8%)
womenashavingGDM.Thestatisticfor
the agreement of GDM diagnosis (be-
tween IADPSG and ADA) was fair
(39.4%). The area under the receiver-
operating characteristic curve (AUC) for
FPG using the IADPSG and ADA criteria
was 0.907 (95% CI 0.899–0.914) and
0.871(0.859–0.882),respectively.Table
1 lists selected threshold values for FPG
with the associated test characteristics.
CONCLUSIONS — TheIADPSGrec-
ommendation that every pregnant
womanshouldundergotheOGTTisvery
demanding; it would severely overload
the laboratory. An urgent, initial FPG re-
sult can assist in deciding if the pregnant
woman should continue with her OGTT
(6).Inthisstudy,usingthetwo-cutoffap-
proach, a higher FPG threshold of 5.1
mmol/l ruled in GDM in 2,975 (28.9%)
womenwith100%speciﬁcity(Table1).A
lower FPG threshold of 4.4 mmol/l
ruled out GDM in 2,228 (21.7%) women
atanacceptablesensitivityof95.4%;only
180 (4.6%) women with GDM were mis-
classiﬁed as healthy. In the Hyperglyce-
mia and Adverse Pregnancy Outcome
Study, risks of adverse outcomes were
low when the FPG was 4.4 mmol/l (3).
Thus, the initial FPG could circumvent
the cumbersome OGTT in over half the
pregnant women without compromising
health care.
The IADPSG criteria increased
GDM prevalence almost threefold com-
pared with the ADA criteria; this would
further add to the health expenditure
due to the additional antenatal visits,
further laboratory work up, and medi-
cations,ifneeded.However,usingthese
moreliberalcriteriadoeshavemanyad-
vantages. In the short term, as con-
ﬁrmed by the recent trials, attaining
glucose targets by diet, exercise, or
drugs would decrease adverse outcome
in index pregnancy. In the long term, a
signiﬁcantly greater number of women
would be identiﬁed to be at risk for type
2 diabetes; this fact is most evident in
Australia (13), because the Australasian
criteria are the most inclusive among
the six major criteria for GDM diagnosis
(2). Thus, these new criteria could be
of real beneﬁt; targeting the “extra”
women with GDM after delivery may
help to forestall the ongoing epidemic
of type 2 diabetes.
The current guidelines for GDM
have numerous shortcomings: they
have often been developed from tenu-
ous data, frequently the result of expert
opinion, sometimes economically
driven, and at times convenience ori-
ented (1). Finally, the long-awaited,
single-guideline—based on sound sci-
entiﬁc data—is available. In many other
areas of medicine, standardization has
been attained with fruitful results (14);
such consistency is crucial for GDM.
Despite the constraints, this unique op-
portunity for one global approach to
GDM should not be missed.
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